Decaestecker K - Search Results

1

Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study.

Steuber T, Jilg C, Tennstedt P, De Bruycker A, Tilki D, Decaestecker K, Zilli T, Jereczek-Fossa BA, Wetterauer U, Grosu AL, Schultze-Seemann W, Heinzer H, Graefen M, Morlacco A, Karnes RJ, Ost P. Steuber T, et al. Among authors: decaestecker k. Eur Urol Focus. 2019 Nov;5(6):1007-1013. doi: 10.1016/j.euf.2018.02.015. Epub 2018 Mar 10. Eur Urol Focus. 2019. PMID: 29530632

2

Extensive profiling of histidine-containing dipeptides reveals species- and tissue-specific distribution and metabolism in mice, rats, and humans.

Van der Stede T, Spaas J, de Jager S, De Brandt J, Hansen C, Stautemas J, Vercammen B, De Baere S, Croubels S, Van Assche CH, Pastor BC, Vandenbosch M, Van Thienen R, Verboven K, Hansen D, Bové T, Lapauw B, Van Praet C, Decaestecker K, Vanaudenaerde B, Eijnde BO, Gliemann L, Hellsten Y, Derave W. Van der Stede T, et al. Among authors: decaestecker k. Acta Physiol (Oxf). 2023 Sep;239(1):e14020. doi: 10.1111/apha.14020. Epub 2023 Jul 24. Acta Physiol (Oxf). 2023. PMID: 37485756

3

Erectile implants in female-to-male transsexuals: our experience in 129 patients.

Hoebeke PB, Decaestecker K, Beysens M, Opdenakker Y, Lumen N, Monstrey SM. Hoebeke PB, et al. Among authors: decaestecker k. Eur Urol. 2010 Feb;57(2):334-40. doi: 10.1016/j.eururo.2009.03.013. Epub 2009 Mar 10. Eur Urol. 2010. PMID: 19303200

4

Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy.

Berkovic P, De Meerleer G, Delrue L, Lambert B, Fonteyne V, Lumen N, Decaestecker K, Villeirs G, Vuye P, Ost P. Berkovic P, et al. Among authors: decaestecker k. Clin Genitourin Cancer. 2013 Mar;11(1):27-32. doi: 10.1016/j.clgc.2012.08.003. Epub 2012 Sep 24. Clin Genitourin Cancer. 2013. PMID: 23010414

5

Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapy.

Van Praet C, Ost P, Lumen N, De Meerleer G, Vandecasteele K, Villeirs G, Decaestecker K, Fonteyne V. Van Praet C, et al. Among authors: decaestecker k. Radiother Oncol. 2013 Nov;109(2):222-8. doi: 10.1016/j.radonc.2013.08.021. Epub 2013 Sep 7. Radiother Oncol. 2013. PMID: 24016674

6

Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: early late toxicity and 3-year clinical outcome.

Fonteyne V, Lumen N, Ost P, Van Praet C, Vandecasteele K, De Gersem Ir W, Villeirs G, De Neve W, Decaestecker K, De Meerleer G. Fonteyne V, et al. Among authors: decaestecker k. Radiother Oncol. 2013 Nov;109(2):229-34. doi: 10.1016/j.radonc.2013.08.006. Epub 2013 Sep 7. Radiother Oncol. 2013. PMID: 24016677

7

Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer.

Ost P, Decaestecker K, Lambert B, Fonteyne V, Delrue L, Lumen N, Ameye F, De Meerleer G. Ost P, et al. Among authors: decaestecker k. Prostate. 2014 Feb;74(3):297-305. doi: 10.1002/pros.22750. Prostate. 2014. PMID: 24395565

8

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence.

Decaestecker K, De Meerleer G, Lambert B, Delrue L, Fonteyne V, Claeys T, De Vos F, Huysse W, Hautekiet A, Maes G, Ost P. Decaestecker K, et al. Radiat Oncol. 2014 Jun 12;9:135. doi: 10.1186/1748-717X-9-135. Radiat Oncol. 2014. PMID: 24920079 Free PMC article.

9

Contemporary minimally-invasive extended pelvic lymph node dissection for prostate cancer before curative radiotherapy: prospective standardized analysis of complications.

Van Praet C, Decaestecker K, Fonteyne V, Ost P, De Visschere P, Verschuere S, Rottey S, Lumen N. Van Praet C, et al. Among authors: decaestecker k. Int J Urol. 2014 Nov;21(11):1138-43. doi: 10.1111/iju.12534. Epub 2014 Jun 25. Int J Urol. 2014. PMID: 24964296

10

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial.

Decaestecker K, De Meerleer G, Ameye F, Fonteyne V, Lambert B, Joniau S, Delrue L, Billiet I, Duthoy W, Junius S, Huysse W, Lumen N, Ost P. Decaestecker K, et al. BMC Cancer. 2014 Sep 15;14:671. doi: 10.1186/1471-2407-14-671. BMC Cancer. 2014. PMID: 25223986 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters